Opinion
Video
Author(s):
The expert panel in hematologyists examines recent WHO and ICC guideline updates, evaluating their impact on the evolving treatment landscape for myelodysplastic syndromes.
TAP Score and CPS May Be Viable for PD-L1 Expression Measurement in Advanced Gastric Cancers
Nivolumab/Ipilimumab/Radiation Combo Produces Responses in Locally Advanced Rectal Cancer
Neoadjuvant Botensilimab/Balstilimab Is Active in Resectable Colon Cancer, Despite MMR Status
TRANSMET Regimen Proves Safe, Feasible for Definitively Unresectable CRC Liver Metastasis
2 Commerce Drive
Cranbury, NJ 08512